Close Menu

Waters

The company's total revenues increased to $584 million from $565 million in the prior-year period, besting the consensus analyst estimate of $582 million.

From research collaborations to corporate acquisitions, attention from the broader scientific community highlighted the field's capabilities and limitations.

Mass spec instrumentation showed solid growth in Q3, with particular strength in academic and government markets.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the third quarter were up 8 percent year over year, driven by broad-based demand for its instrument systems.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has developed a new mass spec workflow that, according to company researchers, combines the advantages of data-independent and data-dependent analyses.

Waters has released its XBridge Protein BEH SEC Columns for size-based separations of protein-based biotherapeutics.

MADRID (GenomeWeb) – With the proteomics field closing in – at least by some measures – on its long-held goal of characterizing the complete human proteome, the question of how to confidently identify and validate the proteins still outstanding received much discussion this week at the Human Prot

NEW YORK (GenomeWeb) – A team led by researchers from Johannes-Gutenberg University Mainz has completed an in-depth proteomic profile of the mouse hippocampus postsynaptic density.

MyCartis this week launched its Evaluation multiplex biomarker analysis system.
The system is intended for simultaneous analysis of multiple protein and nucleic acid markers and features an integrated reaction and detection environment, the company said.

NEW YORK (GenomeWeb) – With their collaboration announced last week, Waters, Imperial College of London, and BGI are aiming to further the integration and clinical translation of genomic and metabolomic information.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.